This is a non-core endpoint: only basic statistics are computed.
See its core counterpart C3_THYROID_FOLLICULAR_EXALLC for full statistics.
Follicular adenocarcinoma of thyroid gland
C3_THYROID_FOLLICULAR
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
222 |
4. Check minimum number of eventsNone |
222 |
5. Include endpointsNone |
222 |
6. Filter based on genotype QC (FinnGen only) |
222 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- First used in FinnGen datafreeze
- DF8
Similar endpoints
↥List of similar endpoints to
Follicular adenocarcinoma of thyroid gland
based on the number of shared cases.
Similar with more cases:
- Follicular adenocarcinoma of thyroid gland, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm of thyroid gland
- Malignant neoplasm of endocrine gland
- Malignant neoplasm of thyroid gland, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm of endocrine gland, excluding all cancers (controls excluding all cancers)
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 222 | 139 | 83 |
| Unadjusted period prevalence (%) | 0.04 | 0.05 | 0.04 |
| Median age at first event (years) | 50.91 | 47.22 | 57.09 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 204
- Matched controls
- 2040
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
8330/3-C73.9
ICD-O-3
Follicular carcinoma, NOS, of thyroid gland
+∞
268.8
194
*
C73.92
ICD-10 Finland
Follicular carcinoma of the thyroid gland
11335.3
228.0
175
*
104
Kela drug reimbursment
Thyroid insufficiency
69.1
129.0
156
91
H03AA01
ATC
levothyroxine sodium; systemic
90.0
118.9
193
332
BAA40
NOMESCO Finland
Unilateral lobectomy of thyroid gland
142.3
104.3
105
15
D44.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Thyroid gland
250.3
80.7
78
5
XX7CT
NOMESCO Finland
Radioiodine therapy of thydoid tissue
275.8
74.7
72
*
JN5PN
NOMESCO Finland
Isotope imaging of secondary neoplasms of thyroid origin
509.5
72.5
68
*
EP1AE
NOMESCO Finland
Neck ultrasound examination
28.9
69.2
98
63
C73.91
ICD-10 Finland
Papillary carcinoma of the thyroid gland (thyroid gland)
126.1
59.9
62
7
BAA60
NOMESCO Finland
Total thyroidectomy
47.6
46.5
56
16
E89.01
ICD-10 Finland
Postsurgical hypothyroidism
67.4
45.2
51
10
JN5AQ
NOMESCO Finland
SPECT of thyroid metastasis with low-dose CT
+∞
37.7
35
*
ZX114
NOMESCO Finland
Intramuscular
79.7
35.4
39
6
C73
ICD-10 Finland
Malignant neoplasm of thyroid gland
380.6
32.9
32
*
E04.1
ICD-10 Finland
Nontoxic single thyroid nodule
40.4
27.5
34
10
E04.2
ICD-10 Finland
Nontoxic multinodular goitre
13.6
23.8
42
38
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
4.4
22.2
119
490
4CJ01
NOMESCO Finland
NA
245.2
22.0
22
*
C73.99
ICD-10 Finland
Malignant tumor of the thyroid gland (thyroid gland), other or unspecified histology
245.2
22.0
22
*
19399
ICD-8 Finland
Malignant neoplasm of thyroid gland
+∞
20.1
19
*
C73.90
ICD-10 Finland
Malignant tumor of the thyroid gland (thyroid gland) without histology
220.5
19.9
20
*
BA1NN
NOMESCO Finland
I-131 dose capsel measurement
196.3
17.8
18
*
BA3AT
NOMESCO Finland
Cytology of thyroid with ultrasound quidance
17.1
14.8
23
15
E04.9
ICD-10 Finland
Nontoxic goitre, unspecified
14.9
14.6
24
18
D34
ICD-10 Finland
Benign neoplasm of thyroid gland
36.9
13.7
17
5
1930B
ICD-9 Finland
Malignant neoplasm of thyroid gland[CARCINOMA FOLLICULARE THYREOIDEAE]
+∞
12.6
12
*
J38.0
ICD-10 Finland
Paralysis of vocal cords and larynx
16.3
11.5
18
12
Z51.88
ICD-10 Finland
Other specified medical care
12.2
11.3
20
18
8335/3-C73.9
ICD-O-3
Follicular carcinoma, minimally invasive of thyroid gland
+∞
10.5
10
*
WW200
NOMESCO Finland
Immunization
9.9
9.8
19
21
E89.2
ICD-10 Finland
Postprocedural hypoparathyroidism
+∞
9.4
9
*
XW1AT
NOMESCO Finland
Biopsy from other organ close to skin with ultrasound quidance
38.5
9.1
11
*
106
Kela drug reimbursment
Hypoparathyroidism
93.8
8.5
9
*
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
2.5
8.2
86
462
WB223
NOMESCO Finland
Demanding adjuvant hormone therapy of malignancy
34.9
8.2
10
*
2506
FHL
Thyroidectomy
83.0
7.5
8
*
JN5SN
NOMESCO Finland
NA
83.0
7.5
8
*
PJ3AT
NOMESCO Finland
Cytology of lymphnode with ultrasound guidance
31.2
7.2
9
*
WX402
NOMESCO Finland
General anaesthesia
2.8
6.7
44
180
WF049
NOMESCO Finland
Radiotherapy of metastasis
7.8
6.5
14
19
E89.09
ICD-10 Finland
Postprocedural hypothyroidism, other or several procedures
72.0
6.5
7
*
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
11.5
6.4
11
10
XX9AQ
NOMESCO Finland
Supplementary SPECT-CT or additional scan
+∞
6.3
6
*
BA1AE
NOMESCO Finland
Thyroiid ultrasound examination
9.0
6.1
12
14
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
54
37
18.96
62.67
1.3
1.4
—
—
—
0
0
169
883
4.83
24.41
12.3
6.5
1.2
1.2
mmol/l
0.40
125
742
158
809
4.31
22.89
9.5
5.5
1.2
1.2
mmol/l
0.44
150
729
203
1359
6.77
18.14
12.4
3.9
17.9
14.9
pmol/l
29.37
193
1216
125
615
3.36
17.73
4.1
3.3
2.3
2.4
mmol/l
3.98
114
537
49
130
4.55
17.49
2.6
3.9
44.9
82.0
ng/l
5.10
39
121
204
1645
3.96
8.21
16.9
4.7
3.4
1.9
mu/l
0.53
194
1493
41
180
2.57
6.26
3.6
3.6
—
—
—
0
0
111
746
1.98
5.81
2.8
2.3
80.1
76.0
nmol/l
0.93
102
657
121
844
1.95
5.62
4.3
4.1
—
—
—
0
0
14
34
4.33
5.44
1.3
1.9
3.2
4.3
iu/l
—
5
11
112
777
1.89
5.14
4.4
4.1
36.4
35.7
g/l
0.82
102
732
173
1413
2.02
4.53
9.7
6.9
75.8
77.2
u/l
0.29
163
1319
26
116
2.41
3.82
1.2
1.2
57.1
168.7
iu/ml
1.59
11
45
75
511
1.71
3.33
4.8
4.1
0.0
0.0
estimate
0.00
35
174
136
1098
1.62
2.99
4.4
4.4
6.3
6.7
mmol/l
1.71
125
1010
14
53
2.75
2.85
2.6
2.1
—
—
—
0
0
131
1067
1.56
2.63
8.3
9.3
3.9
4.1
e9/l
0.42
111
931
94
721
1.53
2.42
4.8
4.1
—
—
—
0
0
120
970
1.52
2.41
7.0
5.7
11.2
10.6
umol/l
0.56
111
918
7
18
3.98
2.27
1.0
1.2
—
—
—
0
0
86
671
1.46
1.95
2.6
3.3
—
—
—
0
0
9
33
2.80
1.95
1.0
1.4
—
—
—
0
0
9
33
2.80
1.95
1.0
1.4
—
—
—
0
0
196
1805
1.73
1.89
20.2
14.4
18.3
22.2
mg/l
1.11
150
1441
199
1842
1.78
1.86
19.3
16.5
139.8
139.6
mmol/l
0.34
193
1785
199
1844
1.76
1.82
19.9
16.6
3.9
4.0
mmol/l
0.85
191
1788
91
740
1.39
1.58
4.1
4.1
21.2
39.3
ng/l
2.13
60
521
57
430
1.44
1.51
2.3
2.2
—
—
—
0
0
166
1516
1.38
1.26
20.6
17.7
13.7
13.7
%
0.12
161
1496
7
144
0.47
1.25
1.4
1.6
—
—
—
0
0
183
1700
1.44
1.24
19.2
13.3
81.5
80.2
ml/min/173m2
0.32
158
1398
11
57
1.98
1.19
4.1
2.9
—
—
—
0
0
0
33
0.00
1.17
0.0
1.1
—
2.8
—
0
16
65
526
1.33
1.12
2.4
3.2
0.3
0.3
e6/l
0.05
51
397
106
923
1.28
1.05
4.6
3.9
0.0
0.0
estimate
0.00
37
178
107
933
1.28
1.05
4.6
4.0
0.0
0.0
estimate
0.00
35
168
5
106
0.46
1.04
4.8
1.6
—
—
—
0
0
50
393
1.35
1.04
1.8
1.8
420.6
452.8
pmol/l
0.33
39
329
5
23
2.20
0.98
1.2
1.2
—
—
—
0
0
0
29
0.00
0.98
0.0
1.1
—
—
—
0
0
0
30
0.00
0.98
0.0
1.2
—
1.1
—
0
11
0
30
0.00
0.98
0.0
1.2
—
1.5
—
0
12
7
36
1.97
0.98
1.4
1.6
—
—
—
0
0
9
51
1.80
0.96
1.3
1.6
—
—
—
0
0
52
421
1.31
0.89
2.7
2.1
4.2
3.2
mg/l
0.86
46
367
14
213
0.63
0.86
4.0
4.8
31.1
32.9
%
—
7
136
61
716
0.80
0.78
2.2
2.0
93.7
96.5
pmol/l
0.19
34
359
5
25
2.02
0.73
1.2
1.4
—
—
—
0
0
5
25
2.02
0.73
1.0
2.9
—
20.3
—
0
7
103
924
1.21
0.72
5.7
5.4
0.0
0.0
estimate
0.00
35
172
5
28
1.80
0.66
2.2
1.3
—
—
—
0
0
198
1912
1.33
0.61
12.5
10.1
23.9
25.0
u/l
0.65
191
1842
7
113
0.61
0.60
1.3
1.3
—
—
—
0
0
161
1687
0.83
0.54
3.8
4.0
1.4
1.3
mmol/l
1.28
145
1549
7
46
1.54
0.49
1.3
1.5
—
—
—
0
0
54
472
1.19
0.48
2.9
2.8
377.0
8451.3
umol/l
2.67
44
397
144
1362
1.16
0.47
4.1
4.0
12.5
12.1
mm/h
0.09
131
1242
7
50
1.41
0.45
1.4
1.6
—
—
—
0
0
28
230
1.25
0.45
8.1
7.9
—
—
—
0
0
30
249
1.24
0.44
2.8
2.4
24.6
21.7
%
0.32
23
220
19
238
0.78
0.43
2.7
6.2
103.5
103.7
mmol/l
0.08
19
230
5
32
1.58
0.42
1.4
1.4
—
—
—
0
0
35
298
1.21
0.41
2.3
1.9
—
—
—
0
0
5
33
1.53
0.41
1.4
1.1
9.4
15.9
u/l
—
5
28
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
5
34
1.48
0.40
1.4
1.5
—
—
—
0
0
0
18
0.00
0.40
0.0
1.1
—
99.3
—
0
18
0
19
0.00
0.39
0.0
1.3
—
299.7
—
0
19
0
19
0.00
0.39
0.0
4.4
—
—
—
0
0
21
170
1.26
0.39
1.4
4.5
2.4
1.8
mmol/l
0.31
13
136
169
1748
0.86
0.38
4.3
4.4
1.4
1.5
mmol/l
0.83
152
1612
14
107
1.33
0.38
2.6
5.9
24.5
24.7
mmol/l
0.11
14
107
6
41
1.48
0.36
1.0
1.2
—
—
—
0
0
6
87
0.68
0.33
1.2
1.5
—
—
—
0
0
16
128
1.27
0.33
1.4
1.3
—
—
—
0
0
64
586
1.13
0.32
2.3
2.3
103.2
55.3
u/l
0.55
53
546
7
53
1.33
0.31
1.4
1.2
—
—
—
0
0
37
415
0.87
0.29
1.4
1.9
1.0
1.3
mg/l
0.48
31
322
31
351
0.86
0.27
3.2
3.6
532.5
171.6
ng/l
0.33
24
276
107
1123
0.91
0.27
3.2
3.1
—
—
—
0
0
28
317
0.87
0.25
1.8
2.8
2.1
1.2
e6/l
0.44
16
183
37
410
0.88
0.25
1.2
1.2
0.7
1.6
u/ml
1.01
14
106
10
78
1.30
0.24
2.6
1.8
0.3
4.4
ug/l
—
10
70
172
1761
0.90
0.24
4.4
4.5
4.6
4.6
mmol/l
0.04
156
1632
162
1662
0.91
0.23
5.6
5.8
39.6
40.0
mmol/mol
0.25
145
1557
5
40
1.26
0.22
2.0
1.3
—
—
—
0
0
5
41
1.22
0.22
1.0
1.3
—
—
—
0
0
5
42
1.19
0.21
1.2
1.6
—
—
—
0
0
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
0
10
0.00
0.21
0.0
5.6
—
234.5
—
0
10
0
10
0.00
0.21
0.0
2.9
—
714.6
—
0
10
26
292
0.88
0.21
1.8
3.1
3.4
2.8
e6/l
0.14
14
159
41
375
1.11
0.21
4.7
4.4
19.8
21.3
%
0.30
21
191
0
12
0.00
0.21
0.0
1.2
—
1.1
—
0
5
0
13
0.00
0.21
0.0
2.2
—
—
—
0
0
24
212
1.15
0.20
1.5
1.8
—
—
—
0
0
24
212
1.15
0.20
1.7
2.4
4.8
6.9
umol/l
1.29
18
185
22
193
1.16
0.20
3.7
4.4
2.7
31.0
ug/l
0.67
17
153
51
475
1.10
0.19
5.7
4.8
2.8
2.7
ug/l
0.07
45
426
18
206
0.86
0.19
2.4
6.4
2.0
1.3
mmol/l
0.51
13
166
7
58
1.21
0.18
1.3
1.3
21.7
20.2
iu/l
—
7
51
7
59
1.19
0.18
4.6
1.8
—
—
—
0
0
165
1615
1.08
0.17
18.3
15.1
40.2
39.9
%
0.12
103
1173
18
204
0.87
0.17
2.7
2.2
—
—
—
0
0
8
73
1.10
0.16
6.9
2.0
—
—
—
0
0
177
1798
0.92
0.15
4.7
5.0
2.8
2.7
mmol/l
0.20
159
1654
45
423
1.08
0.14
5.5
4.0
1.0
1.0
kg/l
0.36
12
54
81
779
1.06
0.14
3.3
2.7
102.4
104.6
ug/l
0.05
72
707
30
278
1.09
0.12
3.9
2.8
0.9
0.8
ug/l
0.22
19
189
33
309
1.08
0.11
1.2
1.3
40.3
13.1
u/ml
0.53
12
125
117
1197
0.95
0.11
3.2
2.9
42.2
43.6
u/l
0.14
99
1127
27
288
0.93
0.09
1.4
1.4
—
—
—
0
0
33
348
0.94
0.08
2.3
1.7
1406.5
1222.3
nmol/l
0.41
22
266
7
64
1.10
0.08
2.4
1.9
—
—
—
0
0
31
327
0.94
0.08
1.5
1.5
—
—
—
0
0
7
68
1.03
0.08
5.4
1.9
—
—
—
0
0
6
72
0.83
0.07
2.5
3.1
4.2
2024.7
u/ml
—
6
65
7
80
0.87
0.07
1.9
1.9
—
—
—
0
0
23
216
1.07
0.07
1.4
1.8
—
—
—
0
0
9
102
0.88
0.06
2.0
2.0
—
—
—
0
0
58
564
1.04
0.06
3.2
3.3
758.7
1392.0
ng/l
2.60
50
485
10
93
1.08
0.02
1.0
1.0
—
—
—
0
0
11
117
0.94
0.02
2.4
6.0
24.3
24.9
mmol/l
0.42
11
110
15
156
0.96
0.00
2.8
3.1
62.7
65.8
ml/min/173m2
—
9
70
18
181
0.99
0.00
2.2
2.0
—
—
—
0
0
175
1746
1.01
0.00
4.5
4.6
5.9
6.0
mmol/l
0.17
157
1603
48
484
0.99
0.00
2.0
1.7
1.5
1.4
mmol/l
0.30
36
407
12
116
1.04
0.00
2.5
3.1
337.8
226.3
ng/l
0.18
12
105
33
328
1.01
0.00
1.2
1.3
21.2
34.1
iu/ml
0.97
12
110
12
125
0.96
0.00
2.0
1.5
—
—
—
0
0
27
272
0.99
0.00
1.8
2.2
29.2
30.0
s
0.37
27
262
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
0
7
0.00
0.00
0.0
1.7
—
69.1
—
0
7
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
0
7
0.00
0.00
0.0
2.7
—
57.1
—
0
7
0
8
0.00
0.00
0.0
3.3
—
—
—
0
0
0
8
0.00
0.00
0.0
3.3
—
—
—
0
0
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
6
64
0.94
0.00
7.2
2.2
0.4
0.9
g/l
—
6
58
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
9
99
0.91
0.00
1.3
3.1
0.9
1.2
%
—
9
99
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
6
64
0.94
0.00
1.8
2.2
—
—
—
0
0
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
6
62
0.97
0.00
7.2
2.0
40.4
38.1
g/l
—
6
54
5
53
0.94
0.00
1.0
1.4
260.2
283.5
miu/ml
—
5
22
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: C3_THYROID_FOLLICULAR – Follicular adenocarcinoma of thyroid gland
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).